Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of November 18, 2026, BDX trades at $215.27 with a market cap of $58.96B and a P/E ratio of 54.36. BDX moved -0.49% today. Year to date, BDX is +8.28%; over the trailing twelve months it is +12.80%. Its 52-week range spans $140.11 to $230.95. Analyst consensus is buy with an average price target of $222.40. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BDX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $215.27 |
| Market Cap | $58.96B |
| P/E Ratio | 54.36 |
| EPS | $3.32 |
| Dividend Yield | 1.06% |
| 52-Week High | $230.95 |
| 52-Week Low | $140.11 |
| Volume | 1.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $23.25B |
| Net Income | $941.00M |
| Gross Margin | 46.93% |
11 analysts cover BDX: 0 strong buy, 5 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $222.40.